15February 17, 2021
Could deep tech companies bring about an age of abundance? Matt Ocko, co-founder and managing partner of Data Collective Venture Capital, joins Azeem Azhar to explore the art of investing in startups that aim to transform entire industries with radically cheaper, cleaner products.
They also discuss:
- Why establishing “computational advantage” is key to a successful deep tech approach.
- How AbCellera, one of Matt’s portfolio companies, used machine learning and extensive automation to swiftly develop an antibody therapy for Covid-19.
- How investors should judge the right time to invest in a new technology.
@mattocko
@azeem
@ExponentialView
Further resources:
- “Materials Built by Microbes: A Revolution in Materials Science” (Exponential View Podcast, 2020)
- “This College Professor Became An Overnight Billionaire Fighting Covid” (Forbes, 2021)
- “With fresh support from its billionaire backers Pivot Bio is ushering in a farming revolution” (TechCrunch, 2020)
HBR Presents is a network of podcasts curated by HBR editors, bringing you the best business ideas from the leading minds in management. The views and opinions expressed are solely those of the authors and do not necessarily reflect the official policy or position of Harvard Business Review or its affiliates.